Acrivon Therapeutics, Inc. · NASDAQ:ACRV
Gamelin Erick received 38,584 Acrivon Therapeutics, Inc. shares as an award (Form 4)
Traded May 18, 2026 · Filed May 20, 2026
On May 18, 2026, Gamelin Erick (Chief Development Officer) received 38,584 Acrivon Therapeutics, Inc. shares as an award, leaving 52,992 shares. Filed May 20, 2026 (Form 4).
- Awarded
- 38,584 shares
- Holding after
- 52,992 shares
- Trading plan
- No
- Role
- Chief Development Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 18, 2026 | Common Stock | Award | 38,584 | 52,992 | Direct |
Source
Related
- Acrivon Therapeutics, Inc.
- Gamelin Erick
- Acrivon Therapeutics, Inc. shareholders
- Form 4 · Gamelin Erick · Aug 20, 2026
- Form 4 · Gamelin Erick · May 18, 2026
- Form 4 · Miller Mary · Oct 7, 2026
- Form 4 · Levin Michaela · Sep 2, 2026
- Form 4 · Blume-Jensen Peter · Aug 27, 2026
- Form 4 · Peterson Katharine · Aug 20, 2026
- Form 4 · Miller Mary · Aug 20, 2026